Enrique Portillo-Salido

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Neuropathic Pain

Spinal Cord Injury

Top Venues

ACS pharmacology & translational science

ACS chemical neuroscience

This page only lists publications with an associated author ORCID identifier.

Publications

Anita Wegert, Menno Monnee, Wouter de Graaf, Frank van Holst, Giovanni Bolcato, José Luis Díaz, Albert Dordal, Enrique Portillo-Salido, Raquel F Reinoso, Sandra Yeste, Antoni Torrens, Carmen Almansa
Towards Multitargeted Ligands as Pain Therapeutics: Dual Ligands of the Ca v α2δ-1 Subunit of Voltage-Gated Calcium Channel and the μ-Opioid Receptor. ChemMedChem 19 (10) (2024)
Anita Wegert, Menno Monnee, Wouter de Graaf, Frank van Holst, Giovanni Bolcato, José Luis Díaz, Albert Dordal, Enrique Portillo-Salido, Raquel F Reinoso, Sandra Yeste, Antoni Torrens, Carmen Almansa
Towards multitargeted ligands as pain therapeutics: Dual ligands of the Ca v α2δ-1 subunit of voltage-gated calcium channel and the μ-opioid receptor. ChemMedChem (2024)
Anita Wegert, Menno Monnee, Wouter de Graaf, Frank van Holst, Giovanni Bolcato, José Luis Díaz, Albert Dordal, Enrique Portillo-Salido, Raquel F Reinoso, Sandra Yeste, Antoni Torrens, Carmen Almansa
Towards Multitargeted Ligands as Pain Therapeutics: Dual Ligands of the Ca v α2δ-1 Subunit of Voltage-Gated Calcium Channel and the μ-Opioid Receptor. ChemMedChem 19 (10) (2024)
Beatriz de la Puente, Daniel Zamanillo, Luz Romero, Alicia Carceller, José Miguel Vela, Manuel Merlos, Enrique Portillo-Salido
Resilience to Pain-Related Depression in σ 1 Receptor Knockout Mice Is Associated with the Reversal of Pain-Induced Brain Changes in Affect-Related Genes. ACS chemical neuroscience (2023)
Beatriz de la Puente, Daniel Zamanillo, Luz Romero, Alicia Carceller, José Miguel Vela, Manuel Merlos, Enrique Portillo-Salido
Comprehensive Preclinical Assessment of Sensory, Functional, Motivational-Affective, and Neurochemical Outcomes in Neuropathic Pain: The Case of the Sigma-1 Receptor. ACS pharmacology & translational science 5 (4) (2022)